These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phenylethanolamine N-methyltransferase. Grunewald GL; Seim MR; Regier RC; Martin JL; Gee CL; Drinkwater N; Criscione KR J Med Chem; 2006 Sep; 49(18):5424-33. PubMed ID: 16942016 [TBL] [Abstract][Full Text] [Related]
3. Exploring the active site of phenylethanolamine N-methyltransferase with 1,2,3,4-tetrahydrobenz[h]isoquinoline inhibitors. Grunewald GL; Seim MR; Regier RC; Criscione KR Bioorg Med Chem; 2007 Feb; 15(3):1298-310. PubMed ID: 17126018 [TBL] [Abstract][Full Text] [Related]
4. Getting the adrenaline going: crystal structure of the adrenaline-synthesizing enzyme PNMT. Martin JL; Begun J; McLeish MJ; Caine JM; Grunewald GL Structure; 2001 Oct; 9(10):977-85. PubMed ID: 11591352 [TBL] [Abstract][Full Text] [Related]
5. Crystallization of PNMT, the adrenaline-synthesizing enzyme, is critically dependent on a high protein concentration. Begun J; McLeish MJ; Caine JM; Palant E; Grunewald GL; Martin JL Acta Crystallogr D Biol Crystallogr; 2002 Feb; 58(Pt 2):314-5. PubMed ID: 11807261 [TBL] [Abstract][Full Text] [Related]
6. Mode of binding of methyl acceptor substrates to the adrenaline-synthesizing enzyme phenylethanolamine N-methyltransferase: implications for catalysis. Gee CL; Tyndall JD; Grunewald GL; Wu Q; McLeish MJ; Martin JL Biochemistry; 2005 Dec; 44(51):16875-85. PubMed ID: 16363801 [TBL] [Abstract][Full Text] [Related]
7. Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine Lu J; Bart AG; Wu Q; Criscione KR; McLeish MJ; Scott EE; Grunewald GL J Med Chem; 2020 Nov; 63(22):13878-13898. PubMed ID: 33147410 [TBL] [Abstract][Full Text] [Related]
8. Design of disulfide-linked thioredoxin dimers and multimers through analysis of crystal contacts. Das M; Kobayashi M; Yamada Y; Sreeramulu S; Ramakrishnan C; Wakatsuki S; Kato R; Varadarajan R J Mol Biol; 2007 Oct; 372(5):1278-92. PubMed ID: 17727880 [TBL] [Abstract][Full Text] [Related]
9. Enzyme adaptation to inhibitor binding: a cryptic binding site in phenylethanolamine N-methyltransferase. Gee CL; Drinkwater N; Tyndall JD; Grunewald GL; Wu Q; McLeish MJ; Martin JL J Med Chem; 2007 Oct; 50(20):4845-53. PubMed ID: 17845018 [TBL] [Abstract][Full Text] [Related]
10. Kinetic and pH studies on human phenylethanolamine N-methyltransferase. Wu Q; McLeish MJ Arch Biochem Biophys; 2013 Nov; 539(1):1-8. PubMed ID: 24018397 [TBL] [Abstract][Full Text] [Related]
12. Molecular recognition of physiological substrate noradrenaline by the adrenaline-synthesizing enzyme PNMT and factors influencing its methyltransferase activity. Drinkwater N; Gee CL; Puri M; Criscione KR; McLeish MJ; Grunewald GL; Martin JL Biochem J; 2009 Aug; 422(3):463-71. PubMed ID: 19570037 [TBL] [Abstract][Full Text] [Related]
13. Structural, mutagenic, and kinetic analysis of the binding of substrates and inhibitors of human phenylethanolamine N-methyltransferase. Wu Q; Gee CL; Lin F; Tyndall JD; Martin JL; Grunewald GL; McLeish MJ J Med Chem; 2005 Nov; 48(23):7243-52. PubMed ID: 16279783 [TBL] [Abstract][Full Text] [Related]
14. Intramolecular disulfide bonds are required for folding hydrolase B into a catalytically active conformation but not for maintaining it during catalysis. Song X; Gragen S; Li Y; Ma Y; Liu J; Yang D; Matoney L; Yan B Biochem Biophys Res Commun; 2004 Jul; 319(4):1072-80. PubMed ID: 15194477 [TBL] [Abstract][Full Text] [Related]
15. Discovery of novel human phenylethanolamine N-methyltransferase (hPNMT) inhibitors using 3D pharmacophore-based in silico, biophysical screening and enzymatic activity assays. Kang DI; Lee JY; Kim W; Jeong KW; Shin S; Yang J; Park E; Chae YK; Kim Y Mol Cells; 2010 Jun; 29(6):595-602. PubMed ID: 20496117 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure of a dimeric oxidized form of human peroxiredoxin 5. Evrard C; Capron A; Marchand C; Clippe A; Wattiez R; Soumillion P; Knoops B; Declercq JP J Mol Biol; 2004 Apr; 337(5):1079-90. PubMed ID: 15046979 [TBL] [Abstract][Full Text] [Related]
17. Structure of the reduced disulfide-bond isomerase DsbC from Escherichia coli. Banaszak K; Mechin I; Frost G; Rypniewski W Acta Crystallogr D Biol Crystallogr; 2004 Oct; 60(Pt 10):1747-52. PubMed ID: 15388920 [TBL] [Abstract][Full Text] [Related]
18. Rapid crystallization of T4 lysozyme by intermolecular disulfide cross-linking. Heinz DW; Matthews BW Protein Eng; 1994 Mar; 7(3):301-7. PubMed ID: 8177878 [TBL] [Abstract][Full Text] [Related]
19. The reaction mechanism of phenylethanolamine N-methyltransferase: a density functional theory study. Georgieva P; Wu Q; McLeish MJ; Himo F Biochim Biophys Acta; 2009 Dec; 1794(12):1831-7. PubMed ID: 19733262 [TBL] [Abstract][Full Text] [Related]
20. Cavity-creating mutation at the dimer interface of Plasmodium falciparum triosephosphate isomerase: restoration of stability by disulfide cross-linking of subunits. Gopal B; Ray SS; Gokhale RS; Balaram H; Murthy MR; Balaram P Biochemistry; 1999 Jan; 38(1):478-86. PubMed ID: 9890931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]